Puma Biotechnology, Inc. (NYSE: PBYI) reported Q2 EPS of ($1.05), $0.39 worse than the analyst estimate of ($0.66).

For earnings history and earnings-related data on Puma Biotechnology, Inc. (PBYI) click here.